PharmAthene (PIP +37%) soars today, after a U.S. court upheld a ruling awarding it a portion of...


PharmAthene (PIP +37%) soars today, after a U.S. court upheld a ruling awarding it a portion of profits received by Siga Technologies (SIGA -2.6%) from its smallpox antiviral drug, ST-246. The decision is just the latest development in what has turned out to be a long-running legal battle between the two companies.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs